KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 156 filers reported holding KURA ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,177,600 | -17.3% | 2,980,000 | -4.0% | 0.42% | -4.9% |
| Q2 2023 | $32,850,900 | -13.5% | 3,105,000 | 0.0% | 0.45% | -20.8% |
| Q1 2023 | $37,974,150 | -1.5% | 3,105,000 | 0.0% | 0.56% | -2.3% |
| Q4 2022 | $38,533,050 | -20.0% | 3,105,000 | -11.9% | 0.58% | -35.3% |
| Q3 2022 | $48,152,000 | -45.3% | 3,525,000 | -26.6% | 0.89% | -48.8% |
| Q2 2022 | $87,984,000 | +14.0% | 4,800,000 | 0.0% | 1.74% | +23.4% |
| Q1 2022 | $77,184,000 | +37.8% | 4,800,000 | +20.0% | 1.41% | +47.8% |
| Q4 2021 | $56,000,000 | -25.3% | 4,000,000 | 0.0% | 0.95% | -19.0% |
| Q3 2021 | $74,920,000 | -13.2% | 4,000,000 | -3.4% | 1.18% | -21.6% |
| Q2 2021 | $86,319,000 | -23.7% | 4,140,000 | +3.5% | 1.50% | -23.1% |
| Q1 2021 | $113,080,000 | -13.4% | 4,000,000 | 0.0% | 1.95% | -13.2% |
| Q4 2020 | $130,640,000 | +75.1% | 4,000,000 | +64.3% | 2.25% | +112.3% |
| Q3 2020 | $74,608,000 | +335.9% | 2,435,000 | +131.9% | 1.06% | +213.6% |
| Q2 2020 | $17,115,000 | – | 1,050,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |